EUVIMEDEUVIMED entdecken
Crossref

Thyroid and liver dysfunction in patients with non-small cell lung cancer (NSCLC) treated with pembrolizumab

Emilia Barańska-Bała, Paulina Małachowska, Sławomir Wileński, Agnieszka Koper, Krzysztof Koper

Medical Research Journal · 15.01.2026 · 11

DOI: 10.5603/mrj.109896 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Research Journal, online erschienen am 15.01.2026. Verfasst von Emilia Barańska-Bała und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Barańska-Bała, E., Małachowska, P., Wileński, S., Koper, A., & Koper, K. (2026). Thyroid and liver dysfunction in patients with non-small cell lung cancer (NSCLC) treated with pembrolizumab. Medical Research Journal, 11(0). https://doi.org/10.5603/mrj.109896

Vancouver

Barańska-Bała E, Małachowska P, Wileński S, Koper A, Koper K. Thyroid and liver dysfunction in patients with non-small cell lung cancer (NSCLC) treated with pembrolizumab. Medical Research Journal. 2026;11(0). doi:10.5603/mrj.109896

BibTeX
@article{BaraskaBaa2026,
  author = {Barańska-Bała, Emilia and Małachowska, Paulina and Wileński, Sławomir and Koper, Agnieszka and Koper, Krzysztof},
  title = {Thyroid and liver dysfunction in patients with non-small cell lung cancer (NSCLC) treated with pembrolizumab},
  journal = {Medical Research Journal},
  year = {2026},
  volume = {11},
  number = {0},
  doi = {10.5603/mrj.109896}
}
Kostenlos starten →